Urgent.News

What's breaking now, across thousands of outlets.

More in Business

Daewoong Holds KOL Summit in Bali

As Daewoong Pharmaceutical’s botulinum toxin product 'Nabota' expands its market dominance after surpassing KRW 1 trillion ($714.29 million) in cumulative global sales, key medical professionals from…

  • Daewoong Pharmaceutical hosted NMC EXCLUSIVE Global KOL Summit Bali 2026 in Indonesia.
  • Summit educated 35 KOLs from 11 countries on advanced Nabota techniques.
  • FDA-approved Nabota saw 57% average annual sales growth since 2019.

More from Tuesday 3 November →